- Tytuł:
-
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and
Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study - Autorzy:
- Źródło:
- Cancer Immunology, Immunotherapy. 72(9):2949-2960
Czasopismo naukowe